Innate microbial sensors and their relevance to allergy

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Risks for infection in patients with asthma (or other atopic conditions): Is asthma more than a chronic airway disease?  Young J. Juhn, MD, MPH  Journal.
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Allergen immunotherapy: A practice parameter third update
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Natalija Novak, MD  Journal of Allergy and Clinical Immunology 
Fatty acids, inflammation, and asthma
Advances in food allergy in 2015
IL-17–producing T cells in lung immunity and inflammation
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Regulation of TH17 cells in the mucosal surfaces
Is 9 more than 2 also in allergic airway inflammation?
Thomas F. Tedder, PhD, Takashi Matsushita, MD, PhD 
Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling  David Bending, PhD,
Fatty acids, inflammation, and asthma
Allergic skin diseases
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Toll-like receptors and atopy
The National Biome Initiative: An allergy perspective
The 3 major types of innate and adaptive cell-mediated effector immunity  Francesco Annunziato, PhD, Chiara Romagnani, MD, PhD, Sergio Romagnani, MD  Journal.
Advances in atopic dermatitis and urticarial in 2016
Etiology of asthma exacerbations
Epithelium: At the interface of innate and adaptive immune responses
Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march  Tali.
IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life 
Reply Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, Michael Tankersley, MD 
Environmental determinants of allergy and asthma in early life
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
News & Notes Journal of Allergy and Clinical Immunology
The Editors' Choice Journal of Allergy and Clinical Immunology
Drivers of chronic rhinosinusitis: Inflammation versus infection
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS 
International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics  Marek Jutel, MD, Ioana Agache, MD, Sergio Bonini,
Cephalosporin Side Chain Cross-reactivity
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
The eosinophil—quo vadis?
Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency  Phil Lieberman, MD, John Routes, MD  The Journal.
Role of regulatory T cells and FOXP3 in human diseases
Autophagy: Nobel Prize 2016 and allergy and asthma research
Advances in the approach to the patient with food allergy
Bart N. Lambrecht, MD, PhD, Hamida Hammad, PhD 
Chemokines and their receptors in allergic disease
Prevention of food allergy: Beyond peanut
Risk of oral food challenges
Eosinophilic esophagitis treated with immunotherapy to dust mites
Thomas Gensollen, PhD, Richard S. Blumberg, MD 
The role of indoor allergens in chronic allergic disease
Erika von Mutius, MD, MSc  Journal of Allergy and Clinical Immunology 
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Innate immune responses to infection
Thunderstorm-related asthma attacks
Endotoxin and the lung: Insight into the host-environment interaction
Update on risk factors for food allergy
Vitamin D in allergic disease: Shedding light on a complex problem
TH2 adjuvants: Implications for food allergy
Asthma: The past, future, environment, and costs
Leonie Hussaarts, MSc, Luciën E. P. M
Genetic regulation of IgE responses: Achilles and the tortoise
Kinase inhibitors in clinical practice: An expanding world
Molecular and cellular mechanisms of food allergy and food tolerance
The future of biologics: Applications for food allergy
Natural history of cow’s milk allergy
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2010  Scott H. Sicherer, MD, Donald Y.M.
Primary prevention of asthma and allergy
Itching as a systemic disease
Presentation transcript:

Innate microbial sensors and their relevance to allergy Andrew H. Liu, MD  Journal of Allergy and Clinical Immunology  Volume 122, Issue 5, Pages 846-858 (November 2008) DOI: 10.1016/j.jaci.2008.10.002 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Innate microbial sensors. Schema of the main categories of microbial pattern recognition receptors at the host-environment interface, and the innate immune cell types that express them. Journal of Allergy and Clinical Immunology 2008 122, 846-858DOI: (10.1016/j.jaci.2008.10.002) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Innate microbial sensors and their relevance to allergy. Microbial PRRs may be relevant to the development of allergy in several ways: (1) some of the innate PRRs (eg, CLRs) can mediate the uptake and presentation of specific allergens (eg, dust mite, grass pollen, fungi) by APCs; (2) low-level activation of microbial PRRs caused by low-level PAMP exposure results in allergen presentation by APCs without IL-12, leading to TH2 lymphocyte development and allergic sensitization; (3) TH2 cytokines IL-4 and IL-13 inhibit the production of AMPs such as cathelicidin and human β-defensins in the skin, rendering the skin susceptible to microbial colonization and infection; (4) microbial PRR activation worsens ongoing allergic inflammation, further impairing AMP production, microbial burden, and disease severity; (5) in contrast, a PAMP-rich and PAMP-diverse environment induces high-level PRR activation, optimized by the cooperative activation of multiple PRR types and the induction of PRR expression that further heightens microbial sensing. High-level PRR activation results in allergen presentation with IL-12, leading to TH1/T regulatory lymphocyte (Treg) responses to allergen, without allergic sensitization. These differences in innate immune responses and development relative to a PAMP-poor versus PAMP-rich environment, and their impact on allergic outcomes, support the hygiene hypothesis and the atopy-protective effect of animal farming environments in early life. Journal of Allergy and Clinical Immunology 2008 122, 846-858DOI: (10.1016/j.jaci.2008.10.002) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions